Sunshine Biopharma (SBFM) Other Working Capital Changes (2016 - 2025)
Historic Other Working Capital Changes for Sunshine Biopharma (SBFM) over the last 13 years, with Q3 2025 value amounting to -$36168.0.
- Sunshine Biopharma's Other Working Capital Changes rose 5680.66% to -$36168.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $166842.0, marking a year-over-year increase of 84106.83%. This contributed to the annual value of $207167.0 for FY2024, which is 87983.73% up from last year.
- Per Sunshine Biopharma's latest filing, its Other Working Capital Changes stood at -$36168.0 for Q3 2025, which was up 5680.66% from -$115617.0 recorded in Q2 2025.
- In the past 5 years, Sunshine Biopharma's Other Working Capital Changes registered a high of $568981.0 during Q1 2024, and its lowest value of -$736637.0 during Q2 2024.
- For the 5-year period, Sunshine Biopharma's Other Working Capital Changes averaged around -$6284.5, with its median value being -$21172.0 (2022).
- As far as peak fluctuations go, Sunshine Biopharma's Other Working Capital Changes skyrocketed by 114848.02% in 2021, and later tumbled by 186044.99% in 2022.
- Over the past 5 years, Sunshine Biopharma's Other Working Capital Changes (Quarter) stood at $4579.0 in 2021, then tumbled by 1860.45% to -$80611.0 in 2022, then skyrocketed by 433.85% to $269120.0 in 2023, then soared by 70.39% to $458558.0 in 2024, then tumbled by 107.89% to -$36168.0 in 2025.
- Its Other Working Capital Changes stands at -$36168.0 for Q3 2025, versus -$115617.0 for Q2 2025 and -$139931.0 for Q1 2025.